S. Palaszynski

发表

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

R Möllby, M. Schenerman, S. Langermann, 2000, The Journal of infectious diseases.

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

S. Langermann, J. Pinkner, S. Hultgren, 1997, Science.

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

M. Hanson, J. Young, J. F. Young, 1993, The Journal of experimental medicine.

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

S. Langermann, S. Koenig, C. K. Stover, 1994, Nature.

An Evaluation of Two Different Schedules of Synthetic Thymosin α1 Administration in Patients with Lung Cancer

A. Goldstein, S. Palaszynski, R. Schulof, 1984 .

Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.

S. Langermann, J. Pinkner, S. Hultgren, 1998, Developments in biological standardization.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A

M. Hanson, S. Langermann, S. Koenig, 1994, The Journal of experimental medicine.

A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.

A. Goldstein, O. Alabaster, P. Cleary, 1985, Journal of biological response modifiers.

T‐cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha‐1

P. Cleary, A. Goldstein, O. Alabaster, 1985, Cancer.

Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897

P. McTamney, Qing Zhu, J. Suzich, 2018, The Journal of infectious diseases.

Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences1

S. Langermann, Herren Wu, Y. Brewah, 2002, The Journal of Immunology.

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

N. Patel, Qing Zhu, J. McAuliffe, 2017, Science Translational Medicine.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A

M. Hanson, S. Langermann, S. Koenig, 1994, Journal of Experimental Medicine.